By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



27220 Turnberry Lane
Suite 200
Valencia  California  91355  U.S.A.
Phone: 800-718-2056 Fax: n/a

QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as the "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer. The company employs more than 3,100 people in over 30 locations worldwide. QIAGEN’s North American headquarters is in Germantown, Maryland and its global headquarters is located in Hilden, Germany.

Further information about QIAGEN can be found at

Key Statistics

Ownership: Public

Web Site: QIAGEN Inc.
Employees: 210
Symbol: QGEN

Company News
MDxHealth, Inc. (MXDHF) Grants QIAGEN Inc. (QGEN) Rights To MSP Technology For QIAsure Methylation Test For Cervical Cancer Risk 6/15/2016 1:49:44 PM
QIAGEN Inc. (QGEN) Integrates Quality Control Tools Into Genereader NGS System 6/1/2016 2:46:40 PM
QIAGEN Inc. (QGEN) Reports Results For First Quarter of 2016 4/28/2016 9:01:58 AM
COSMOSID Announces Partnership With QIAGEN Inc. (QGEN) For Microbial Analysis 2/3/2016 9:16:48 AM
COSMOSID Announces Partnership With QIAGEN Inc. (QGEN) For Microbial Analysis 2/3/2016 6:26:13 AM
QIAGEN Inc. (QGEN) To Supply QuantiFERON-TB Tests To Ease Tuberculin Shortage 1/26/2016 7:54:06 AM
QIAGEN Inc. (QGEN) Introduces GeneReader NGS System 11/5/2015 6:52:03 AM
QIAGEN Inc. (QGEN) Launches New Bioinformatics Solution For Hereditary Diseases 10/7/2015 3:37:00 PM
QIAGEN Inc. (QGEN) Launches New Genetic Fingerprinting Kits For U.S. Forensic Labs 6/18/2015 6:36:43 AM
Hitachi High-Technologies Corporation And QIAGEN Inc. (QGEN) Enter Into Long-Term Strategic Collaboration For Molecular Testing 6/18/2015 6:12:34 AM